<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04110054</url>
  </required_header>
  <id_info>
    <org_study_id>1812VA323</org_study_id>
    <nct_id>NCT04110054</nct_id>
  </id_info>
  <brief_title>Evaluation of S-600918 in Adults With Refractory Chronic Cough</brief_title>
  <official_title>A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-selection Study of S-600918 in Patients With Refractory Chronic Cough</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shionogi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shionogi Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the optimal dose of S-600918 in patients
      with refractory chronic cough by evaluating the change from baseline in 24-hour cough
      frequency (coughs per hour) with S-600918 compared with placebo.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2020</start_date>
  <completion_date type="Anticipated">May 25, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 25, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cough at Week 4 Calculated as the Ratio of Number of Coughs per Hour in 24 Hours at Week 4 to Baseline</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour for 24 hours will be measured using a cough monitor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour in 24 Hours by ≥ 30%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour for 24 hours will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour in 24 Hours by ≥ 50%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour for 24 hours will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour in 24 Hours by ≥ 70%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour for 24 hours will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cough at Week 4 Calculated as the Ratio of the Number of Coughs per Hour While Awake at Week 4 to Baseline</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour while awake will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour While Awake by ≥ 30%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour while awake will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour While Awake by ≥ 50%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour while awake will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with a Reduction from Baseline in the Number of Coughs per Hour While Awake by ≥ 70%</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour while awake will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cough at Week 4 Calculated as the Ratio of the Number of Coughs per Hour While Asleep at Week 4 to Baseline</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The number of coughs per hour while asleep will be measured using a cough monitor.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Weekly Cough Severity</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>Cough severity will be assessed by the participant on a 100 mm visual analog scale where higher scores indicate worse severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline through Day 7 in Daily Cough Severity</measure>
    <time_frame>Baseline and Day 7</time_frame>
    <description>Cough severity will be assessed by the participant on a 100 mm visual analog scale where higher scores indicate worse severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Leicester Cough Questionnaire (LCQ)</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The LCQ is a patient-reported quality of life (QOL) measure of chronic cough. The questionnaire consists of 19 items to which the patient responds on a 7-point Likert response scale (from 1 to 7). Each item assesses symptoms during cough and the effect of cough on 3 main domains: physical, psychological and social. Domain scores range from 1-7, and the total score ranges from 3 - 21; a higher score indicates a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with an Increase in LCQ of ≥ 1.3 points</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The LCQ is a patient-reported quality of life (QOL) measure of chronic cough. The questionnaire consists of 19 items to which the patient responds on a 7-point Likert response scale (from 1 to 7). Each item assesses symptoms during cough and the effect of cough on 3 main domains: physical, psychological and social. Domain scores range from 1-7, and the total score ranges from 3 - 21; a higher score indicates a better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The ICIQ-SF is a patient-reported measure of the severity of urinary incontinence and quality of life (QOL) for those with urinary incontinence. The questionnaire consists of 4 items that evaluate the frequency, severity, and impact of urinary incontinence on QOL. A total score ranging from 0-21 is possible for 3 of the 4 items combined, where a higher score indicates more severe symptoms. The 1 item remaining is not given a score; rather, the patient selects one description out of 8 possible descriptions of this item.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Short Form (36) Health Survey (SF-36)</measure>
    <time_frame>Baseline and Week 4</time_frame>
    <description>The SF-36 is a patient-reported measure of overall health status. The questionnaire consists of 8 scaled scores (health concepts) and evaluates vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. Scores for each scale range from 0 to 100; the lower the score, the greater the disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC)</measure>
    <time_frame>Week 4</time_frame>
    <description>The PGIC is a patient-reported measure of overall health status and consists of one item adapted from the Clinical Global Impressions scale. The patient selects one description out of 7 possible descriptions of this item. The descriptions are numbered from 1 through 7, where the most favorable description is numbered as 1 and the least favorable description is numbered as 7.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">372</enrollment>
  <condition>Chronic Cough</condition>
  <arm_group>
    <arm_group_label>S-600918 50 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 50 mg S-600918 orally once a day for 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S-600918 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 150 mg S-600918 orally once a day for 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S-600918 300 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive 300 mg S-600918 orally once a day for 28 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive placebo to S-600918 orally once a day for 28 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-600918</intervention_name>
    <description>Tablets for oral administration</description>
    <arm_group_label>S-600918 150 mg</arm_group_label>
    <arm_group_label>S-600918 300 mg</arm_group_label>
    <arm_group_label>S-600918 50 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo to S-600918</intervention_name>
    <description>Tablets for oral administration</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Having refractory chronic cough (including unexplained chronic cough) for at least 1
             year.

          -  If female and of childbearing potential, agreement to use one of the allowed
             contraceptive methods.

          -  Capable of giving signed informed consent.

        Key Exclusion Criteria:

          -  Currently smokes or uses potentially irritating inhalational agents (eg, e-cigarettes,
             smokeless cigarettes, vaping); stopped smoking or using potentially irritating
             inhalational agents within the last year; or has a smoking history of 20 pack-years or
             more.

          -  Has chronic obstructive pulmonary disease or uncontrolled asthma.

          -  Has a clinically unstable medical condition.

          -  History of or ongoing significant psychiatric disorder.

          -  History of respiratory tract infection or significant change in lung function or a
             pulmonary condition in the last 4 weeks.

          -  History of malignancy in the last 5 years.

          -  History of severe drug allergy.

          -  History of alcohol or drug abuse in the last year or currently uses any form of
             marijuana or illicit drugs.

          -  Has a clinically significant finding on a chest x-ray or chest computed tomography
             (CT) scan in the last year.

          -  Has systolic blood pressure &gt; 160 mm Hg or diastolic blood pressure &gt; 90 mm Hg.

          -  Received S-600918 previously.

          -  Received an investigational drug in the last 3 months.

          -  Received an angiotensin converting enzyme (ACE) inhibitor in the last 3 months or
             requires such treatment.

          -  Has a positive serologic test for human immunodeficiency virus (HIV) antigen or
             antibody, hepatitis B virus surface antigen, or hepatitis C virus ribonucleic acid
             (RNA).

          -  If female, pregnant or trying to become pregnant or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shionogi Clinical Trials Administrator Clinical Support Help Line</last_name>
    <role>Study Director</role>
    <affiliation>Shionogi</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shionogi Clinical Trials Administrator Clinical Support Help Line</last_name>
    <phone>800-849-9707</phone>
    <email>Shionogiclintrials-admin@shionogi.co.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Research Solutions of Arizona</name>
      <address>
        <city>Litchfield Park</city>
        <state>Arizona</state>
        <zip>85340</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pulmonary Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alliance for Multispecialty Research</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85283</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>California Medical Research Associates, Inc.</name>
      <address>
        <city>Northridge</city>
        <state>California</state>
        <zip>91324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institute of HealthCare Assessment, Inc.</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sher Allergy Specialist/Center for Cough</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33778</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lenus Research &amp; Medical Group, LLC</name>
      <address>
        <city>Sweetwater</city>
        <state>Florida</state>
        <zip>33172</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Lung Center</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Minnesota Lung Center</name>
      <address>
        <city>Woodbury</city>
        <state>Minnesota</state>
        <zip>55125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Montana Medical Research, Inc.</name>
      <address>
        <city>Missoula</city>
        <state>Montana</state>
        <zip>59808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>American Health Research Inc</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Gastonia</name>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <zip>28504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southeastern Research Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>New Horizons Clinical Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research Associaes of Central PA, LLC</name>
      <address>
        <city>DuBois</city>
        <state>Pennsylvania</state>
        <zip>15801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AAPRI Clinical Research Institute</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02886</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>ADAC Research, PA</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research of Rock Hill</name>
      <address>
        <city>Rock Hill</city>
        <state>South Carolina</state>
        <zip>29732</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pharmaceutical Research &amp; Consulting, Inc</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Metroplex Pulmonary and Sleep Center</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diagnostics Research Group</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Allergy and Asthma Care of Waco</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Allergy Asthma Research Institute</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Intermountain Clinical Research</name>
      <address>
        <city>Draper</city>
        <state>Utah</state>
        <zip>84020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tidewater Physicians Multispecialty Group Clinical Research</name>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pneumologie Varnsdorf s.r.o.</name>
      <address>
        <city>Varnsdorf</city>
        <zip>407 47</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nagoya City University Hospital</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>467-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fukui Prefectural Hospital</name>
      <address>
        <city>Fukui-shi</city>
        <state>Fukui</state>
        <zip>910-8526</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nishi Fukuoka Hospital</name>
      <address>
        <city>Fukuoka-shi</city>
        <state>Fukuoka</state>
        <zip>819-8555</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fukushima Medical University Hospital</name>
      <address>
        <city>Fukushima-shi,</city>
        <state>Fukushima</state>
        <zip>960-1295</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tohno Chuo Clinic</name>
      <address>
        <city>Mizunami-shi</city>
        <state>Gifu</state>
        <zip>509-6134</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Idaimae Minamiyojo Int Clinic</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>﻿064-0804</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nakatani Hospital</name>
      <address>
        <city>Himeji</city>
        <state>Hyogo</state>
        <zip>672-8064</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hitachi , Ltd. Hitachinaka General Hospital</name>
      <address>
        <city>Hitachinaka-shi</city>
        <state>Ibaraki</state>
        <zip>312-0057</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fujisawa City Hospital</name>
      <address>
        <city>Fujisawa</city>
        <state>Kanagawa</state>
        <zip>251-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lee's Clinic</name>
      <address>
        <city>Osaka-shi</city>
        <state>Osaka</state>
        <zip>531-0073</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Japan Organization of Occupational Health and Safety Hamamatsu Rosai Hospital</name>
      <address>
        <city>Hamamatsu-shi</city>
        <state>Shizuoka</state>
        <zip>430-8525</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nihonbashi Medical &amp; Allergy Clinic</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>103-0022</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fukuwa Clinic</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0031</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Takahashi Medical Clinic</name>
      <address>
        <city>Kokubunji-shi</city>
        <state>Tokyo</state>
        <zip>185-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>KONO Medical Clinic</name>
      <address>
        <city>Setagaya-ku,</city>
        <state>Tokyo</state>
        <zip>157-0072</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yoga Allergy Clinic</name>
      <address>
        <city>Setagaya</city>
        <state>Tokyo</state>
        <zip>158-0097</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Koukokukai Ebisu Clinic</name>
      <address>
        <city>Shibuya-shi</city>
        <state>Tokyo</state>
        <zip>150-0013</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tokyo Shinagawa Hospital Medical Corporation Association Tokyokyojuno-kai</name>
      <address>
        <city>Shinagawa-ku</city>
        <state>Tokyo</state>
        <zip>140-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kouwakai Kouwa Clinic</name>
      <address>
        <city>Toshima-ku</city>
        <state>Tokyo</state>
        <zip>170-0003</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Senzoku Kokyuuki Allergy Clinic</name>
      <address>
        <city>Ota-ku</city>
        <state>Toyko</state>
        <zip>145-0063</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shimonoseki City Hospital</name>
      <address>
        <city>Shimonoseki-shi</city>
        <state>Yamaguchi</state>
        <zip>750-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kamei Internal Medicine and Respiratory Clinic</name>
      <address>
        <city>Kagawa</city>
        <zip>761-8073</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Ibarakihigashi National Hospital</name>
      <address>
        <city>Naka-gun</city>
        <zip>319-1113</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Sagamihara National Hospital</name>
      <address>
        <city>Sagamihara-shi, Kanagawa</city>
        <zip>252-0392</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shizuoka General Hospital</name>
      <address>
        <city>Shizuoka-shi</city>
        <zip>420-8527</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaiseikai Kita Shin Yokohama Internal Medicine Clinic</name>
      <address>
        <city>Yokohama</city>
        <zip>223-0059</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chernihiv City Hospital #2, Therapy Department</name>
      <address>
        <city>Chernihiv</city>
        <zip>14034</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital #13</name>
      <address>
        <city>Kharkiv</city>
        <zip>61124</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center of LLC Medical Clinic Blagomed</name>
      <address>
        <city>Kyiv</city>
        <zip>01023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Institute of Phthisiology and Pulmonology, Department of Pulmonology</name>
      <address>
        <city>Kyiv</city>
        <zip>03038</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>The 1st City Clinical Hospital of Poltava City Council</name>
      <address>
        <city>Poltava</city>
        <zip>36039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Japan</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2019</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>P2X3 receptor antagonist</keyword>
  <keyword>Refractory chronic cough</keyword>
  <keyword>S-600918</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

